Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A digital pillbox that tracks medication openings and sends text reminders helped young people with HIV in Zimbabwe achieve better viral suppression after 6 months compared to standard counseling. But the gains faded once the device was taken away. The findings highlight both the promise and the limits of tech-based adherence tools for youth living with HIV.
A randomized trial published in The Lancet Regional Health – Africa found that a digital pillbox — one that logs when it's opened and fires off a text reminder if a dose is missed — significantly improved viral suppression in young people with HIV (PWH) in Zimbabwe. Paired with monthly one-on-one adherence feedback sessions, the device outperformed enhanced counseling alone over a 6-month period.
The catch? The benefits didn't stick. Three months after the device was removed, suppression rates between the two groups were virtually identical — and viral rebound was numerically higher among those who had used the device, though not statistically significant.
By the Numbers:
Why it matters: Adherence to antiretroviral therapy is a persistent challenge among young PWH, especially in low-resource settings. While digital tools show real short-term promise, this trial underscores that sustainable HIV care for youth requires solutions that go beyond the device itself — think long-term integration, affordability, and youth-centered support systems.
